STATE STREET CORP - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 133 filers reported holding ARCUS BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.5%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$75,390,431
-14.5%
4,200,024
-3.3%
0.00%
-20.0%
Q2 2023$88,191,057
-12.0%
4,342,248
-21.0%
0.01%
-16.7%
Q1 2023$100,251,248
-31.6%
5,496,253
-22.5%
0.01%
+50.0%
Q4 2022$146,591,544
+35.3%
7,088,566
+71.1%
0.00%
-42.9%
Q3 2022$108,356,000
-3.6%
4,142,060
-6.6%
0.01%0.0%
Q2 2022$112,404,000
+29.5%
4,435,849
+61.3%
0.01%
+75.0%
Q1 2022$86,787,000
-2.2%
2,749,919
+25.5%
0.00%0.0%
Q4 2021$88,707,000
+9.1%
2,191,931
-6.0%
0.00%0.0%
Q3 2021$81,304,000
+10.2%
2,331,630
-13.2%
0.00%0.0%
Q2 2021$73,749,000
+21.3%
2,685,701
+24.0%
0.00%
+33.3%
Q1 2021$60,804,000
+28.5%
2,165,394
+18.8%
0.00%0.0%
Q4 2020$47,321,000
+9.6%
1,822,855
-27.6%
0.00%0.0%
Q3 2020$43,167,000
+9.9%
2,518,468
+58.6%
0.00%0.0%
Q2 2020$39,275,000
+339.7%
1,587,499
+146.7%
0.00%
+200.0%
Q1 2020$8,932,000
+38.1%
643,537
+0.5%
0.00%
Q4 2019$6,469,000
+15.2%
640,467
+3.8%
0.00%
Q3 2019$5,617,000
+15.6%
617,246
+1.0%
0.00%
Q2 2019$4,858,000
-28.2%
611,113
+12.9%
0.00%
-100.0%
Q1 2019$6,762,000
+23.1%
541,375
+6.1%
0.00%0.0%
Q4 2018$5,495,000
+338.9%
510,243
+467.8%
0.00%
Q3 2018$1,252,000
+58.1%
89,862
+38.9%
0.00%
Q2 2018$792,00064,7000.00%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q3 2021
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$28,936,78218.14%
Octagon Capital Advisors LP 1,968,000$35,325,6005.43%
Decheng Capital Management III (Cayman), LLC 869,790$15,612,7315.21%
Boxer Capital, LLC 1,602,200$28,759,4901.53%
SECTORAL ASSET MANAGEMENT INC 375,456$6,739,4351.31%
DAFNA Capital Management LLC 222,717$3,997,7701.24%
PFM Health Sciences, LP 1,405,056$25,220,7551.19%
Ikarian Capital, LLC 4,000$7,180,0000.86%
Capital Impact Advisors, LLC 24,280$435,8260.73%
Parkman Healthcare Partners LLC 205,109$3,681,7070.68%
View complete list of ARCUS BIOSCIENCES INC shareholders